Back
Aligos Therapeutics Stock Price Chart

Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ALGS
Aligos Therapeutics
Last Price:
$20.98
Seasonality Move:
-24.57%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
Aligos Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.46 | Sell |
20-day SMA: | 27.71 | Sell |
50-day SMA: | 32.07 | Sell |
200-day SMA: | 17.81 | Buy |
8-day EMA: | 25.38 | Sell |
20-day EMA: | 27.68 | Sell |
50-day EMA: | 28.15 | Sell |
200-day EMA: | 21.58 | Sell |
Aligos Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.21 | Sell |
Relative Strength Index (14 RSI): | 34.79 | Sell |
Chaikin Money Flow: | -518328 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.35 - 34.19) | Sell |
Bollinger Bands (100): | (9.82 - 33.5) | Sell |
Aligos Therapeutics Technical Analysis
Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 21.01 while ALGS 8-day simple moving average is 25.46, which is a Sell signal.
-
The stock price of ALGS is 21.01 while Aligos Therapeutics 20-day SMA is 27.71, which makes it a Sell.
-
Aligos Therapeutics 50-day simple moving average is 32.07 while ALGS share price is 21.01, making it a Sell technically.
-
ALGS stock price is 21.01 and Aligos Therapeutics 200-day simple moving average is 17.81, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Sell
37
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a SellThe current Aligos Therapeutics [ALGS] share price is $21.01. The Score for ALGS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
75.4M
Price in USD:
21.01
Share Volume:
713.1K
Aligos Therapeutics 52-Week Range
52-Week High:
46.80
52-Week Low:
6.76
Sell
37
Aligos Therapeutics (ALGS)
is a Sell
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?The Aligos Therapeutics stock price is 21.01 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is overvalued.
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 21.01 while ALGS 8-day exponential moving average is 25.38, which is a Sell signal.
-
The stock price of ALGS is 21.01 while Aligos Therapeutics 20-day EMA is 27.68, which makes it a Sell.
-
Aligos Therapeutics 50-day exponential moving average is 28.15 while ALGS share price is 21.01, making it a Sell technically.
-
ALGS stock price is 21.01 and Aligos Therapeutics 200-day simple moving average is 21.58, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is -2.21, suggesting Aligos Therapeutics is a Sell
-
Aligos Therapeutics Relative Strength Index (RSI) is 34.79, which suggest Aligos Therapeutics is oversold
-
The Bollinger Bands (25) for Aligos Therapeutics is (24.35 - 34.19), which suggest Aligos Therapeutics is a Sell
-
The Bollinger Bands (100) for Aligos Therapeutics is (9.82 - 33.5), which suggest Aligos Therapeutics is a Sell
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.